Institutional investors purchased a net $24.8 million shares of TEVA during the quarter ended September 2016, and now own 57.41% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NNIP ADVISORS BV Bought 1.4 Million shares of Teva Pharmaceutical
NATIONAL PENSION SERVICE OF KORE... Bought 674.3 Thousand shares of Teva Pharmaceutical